Image 1 of 1
AOD-9604 10 MG
AOD-9604
Course Target: Metabolic Regulation, Lipolytic Pathways, and Obesity Therapeutics
Core Focal Point: Selective \(\beta _{3}\)-Adrenergic Agonism, Lipolysis Stimulation, and Glycemic Neutrality.
1. Molecular Structure & Origin
AOD-9604 is a synthetic 16-amino acid peptide fragment modeled exactly after the C-terminal region of human growth hormone, spanning amino acids 176 through 191. [1, 2]
The Structural Modification: A single tyrosine residue is substituted at the N-terminus to replace the native phenylalanine.
The Purpose: This minor alteration drastically stabilizes the molecule against rapid enzymatic degradation, allowing it to function effectively in human blood. [1]
2. 🎯 The Cellular Mechanism: Burning Fat Without Growth Signals
To explain its cellular advantage to your class, use the phrase "The Isolated Lipolytic Tool." Unlike full-length HGH, which binds to growth hormone receptors to trigger systemic cell growth, AOD-9604 operates through an entirely separate, non-hormonal pathway. [1, 2]
[AOD-9604 Subcutaneous Injection]
│
▼
[Bypasses Growth Hormone Receptors / Ignores Liver IGF-1]
│
▼
[Selectively Binds to β3-Adrenergic Receptors on Fat Cells]
│
▼
┌────────────────────────────┴────────────────────────────┐
▼ ▼
[Triggers Lipolysis (HSL Activation)] [Inhibits Lipogenesis]
│ │
▼ ▼
[Breaks Down Stored Triglycerides] [Blocks Free Fatty Acids From]
│ [Forming New Fat Stores]
▼
[Free Fatty Acids Released for Beta-Oxidation]
Step 1: Ignoring the Upstream Master Switch
When injected, AOD-9604 completely ignores the liver and does not trigger the release of IGF-1. Because of this, it carries zero risk of causing cancer proliferation, internal organ enlargement (visceromegaly), or joint swelling—the exact dangers of the IGF-1 LR3 or HGH therapies we previously reviewed.
Step 2: Selective Receptor Binding
Instead, AOD-9604 targets the outer walls of fat cells (adipocytes), where it upregulates and activates \(\beta _{3}\)-adrenergic receptors.
Step 3: Dual Metabolic Function (Lipolysis + Anti-Lipogenesis)
Lipolysis (Fat Breakdown): It activates Hormone-Sensitive Lipase (HSL), commanding the fat cell to immediately break its bulky stored triglycerides down into fluid free fatty acids and glycerol, dumping them into the blood to be burned as raw energy.
Anti-Lipogenesis (Fat Blocking): Simultaneously, it inhibits lipogenesis. It blocks circulating un-used fats and sugars from being absorbed and turned into new fat tissue.
AOD-9604 is a non-hormonal scalpel. It bypasses the brain entirely and targets fat cell receptors directly, triggering local fat breakdown while ensuring blood sugar and insulin levels remain completely undisturbed.
Why Fasting is Mandatory.
To give your class real-world clinical context, emphasize that AOD-9604 requires a strictly fasted state to work.
If a patient eats before administration, insulin levels rise.
Elevated insulin acts as a powerful biological block against Hormone-Sensitive Lipase (HSL), completely neutralizing and shutting down AOD-9604's ability to trigger fat breakdown
⏰ The Gold Standard Protocol: Morning Fasted
The absolute best time to administer AOD-9604 is first thing in the morning upon waking.
The Reason: Your body has just completed a natural 8-to-10 hour overnight fast.
The State: Your baseline insulin levels are at their absolute lowest, and glucagon (the fat-releasing hormone) is elevated.
The Process: You inject, wait 30 to 45 minutes, and then consume breakfast or complete fasted exercise. This maximizes fat mobilization.
🌙 If You Must Take It at Night
If your schedule forces you to take AOD-9604 in the evening, you must adjust your fasting window: [1]
The 4-Hour Rule: Wait at least 3 to 4 hours after your last bite of food before injecting. This ensures insulin has completely cleared from circulation.
The Carbohydrate Factor: If your dinner was high in carbohydrates or fats, insulin remains elevated much longer than a light, protein-heavy meal.
Product Details
• Compound: AOD-9604
• Quantity: 10 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
Assumption of Risk: "By purchasing, the buyer acknowledges that they are a qualified researcher, that products are not misbranded, and that they assume all risks associated with the handling and use of these products"
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.
AOD-9604
Course Target: Metabolic Regulation, Lipolytic Pathways, and Obesity Therapeutics
Core Focal Point: Selective \(\beta _{3}\)-Adrenergic Agonism, Lipolysis Stimulation, and Glycemic Neutrality.
1. Molecular Structure & Origin
AOD-9604 is a synthetic 16-amino acid peptide fragment modeled exactly after the C-terminal region of human growth hormone, spanning amino acids 176 through 191. [1, 2]
The Structural Modification: A single tyrosine residue is substituted at the N-terminus to replace the native phenylalanine.
The Purpose: This minor alteration drastically stabilizes the molecule against rapid enzymatic degradation, allowing it to function effectively in human blood. [1]
2. 🎯 The Cellular Mechanism: Burning Fat Without Growth Signals
To explain its cellular advantage to your class, use the phrase "The Isolated Lipolytic Tool." Unlike full-length HGH, which binds to growth hormone receptors to trigger systemic cell growth, AOD-9604 operates through an entirely separate, non-hormonal pathway. [1, 2]
[AOD-9604 Subcutaneous Injection]
│
▼
[Bypasses Growth Hormone Receptors / Ignores Liver IGF-1]
│
▼
[Selectively Binds to β3-Adrenergic Receptors on Fat Cells]
│
▼
┌────────────────────────────┴────────────────────────────┐
▼ ▼
[Triggers Lipolysis (HSL Activation)] [Inhibits Lipogenesis]
│ │
▼ ▼
[Breaks Down Stored Triglycerides] [Blocks Free Fatty Acids From]
│ [Forming New Fat Stores]
▼
[Free Fatty Acids Released for Beta-Oxidation]
Step 1: Ignoring the Upstream Master Switch
When injected, AOD-9604 completely ignores the liver and does not trigger the release of IGF-1. Because of this, it carries zero risk of causing cancer proliferation, internal organ enlargement (visceromegaly), or joint swelling—the exact dangers of the IGF-1 LR3 or HGH therapies we previously reviewed.
Step 2: Selective Receptor Binding
Instead, AOD-9604 targets the outer walls of fat cells (adipocytes), where it upregulates and activates \(\beta _{3}\)-adrenergic receptors.
Step 3: Dual Metabolic Function (Lipolysis + Anti-Lipogenesis)
Lipolysis (Fat Breakdown): It activates Hormone-Sensitive Lipase (HSL), commanding the fat cell to immediately break its bulky stored triglycerides down into fluid free fatty acids and glycerol, dumping them into the blood to be burned as raw energy.
Anti-Lipogenesis (Fat Blocking): Simultaneously, it inhibits lipogenesis. It blocks circulating un-used fats and sugars from being absorbed and turned into new fat tissue.
AOD-9604 is a non-hormonal scalpel. It bypasses the brain entirely and targets fat cell receptors directly, triggering local fat breakdown while ensuring blood sugar and insulin levels remain completely undisturbed.
Why Fasting is Mandatory.
To give your class real-world clinical context, emphasize that AOD-9604 requires a strictly fasted state to work.
If a patient eats before administration, insulin levels rise.
Elevated insulin acts as a powerful biological block against Hormone-Sensitive Lipase (HSL), completely neutralizing and shutting down AOD-9604's ability to trigger fat breakdown
⏰ The Gold Standard Protocol: Morning Fasted
The absolute best time to administer AOD-9604 is first thing in the morning upon waking.
The Reason: Your body has just completed a natural 8-to-10 hour overnight fast.
The State: Your baseline insulin levels are at their absolute lowest, and glucagon (the fat-releasing hormone) is elevated.
The Process: You inject, wait 30 to 45 minutes, and then consume breakfast or complete fasted exercise. This maximizes fat mobilization.
🌙 If You Must Take It at Night
If your schedule forces you to take AOD-9604 in the evening, you must adjust your fasting window: [1]
The 4-Hour Rule: Wait at least 3 to 4 hours after your last bite of food before injecting. This ensures insulin has completely cleared from circulation.
The Carbohydrate Factor: If your dinner was high in carbohydrates or fats, insulin remains elevated much longer than a light, protein-heavy meal.
Product Details
• Compound: AOD-9604
• Quantity: 10 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
Assumption of Risk: "By purchasing, the buyer acknowledges that they are a qualified researcher, that products are not misbranded, and that they assume all risks associated with the handling and use of these products"
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.